These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24446303)

  • 1. Application of genomics and proteomics in drug target discovery.
    Zhang HM; Nan ZR; Hui GQ; Liu XH; Sun Y
    Genet Mol Res; 2014 Jan; 13(1):198-204. PubMed ID: 24446303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target discovery from data mining approaches.
    Yang Y; Adelstein SJ; Kassis AI
    Drug Discov Today; 2009 Feb; 14(3-4):147-54. PubMed ID: 19135549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerating the discovery of new drug targets with chemical proteomics.
    Cheung AK; Jain RK
    IDrugs; 2010 Dec; 13(12):862-8. PubMed ID: 21154144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics in the assessment of a multi-component, multi-target medication in soft tissue disorders.
    St Laurent G; Kapranov P
    Curr Med Res Opin; 2013; 29 Suppl 2():11-4. PubMed ID: 23517420
    [No Abstract]   [Full Text] [Related]  

  • 7. [Discovery of drug targets by quantitative proteomics and their clinical application].
    Tomonaga T
    Nihon Yakurigaku Zasshi; 2017; 149(3):123-127. PubMed ID: 28260742
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomics and transcriptomics in drug discovery.
    Dopazo J
    Drug Discov Today; 2014 Feb; 19(2):126-32. PubMed ID: 23773860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target identification of small molecules based on chemical biology approaches.
    Futamura Y; Muroi M; Osada H
    Mol Biosyst; 2013 May; 9(5):897-914. PubMed ID: 23354001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics and proteomics tools for compound mode-of-action studies in drug discovery.
    Kley N; Ivanov I; Meier-Ewert S
    Pharmacogenomics; 2004 Jun; 5(4):395-404. PubMed ID: 15165175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.
    Russell C; Rahman A; Mohammed AR
    Ther Deliv; 2013 Mar; 4(3):395-413. PubMed ID: 23442083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of chemistry-based functional proteomics to screening for novel drug targets.
    Yuan K; Lei Y; Huang C
    Comb Chem High Throughput Screen; 2010 Jun; 13(5):414-21. PubMed ID: 20156143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics and genomics of microgravity.
    Nichols HL; Zhang N; Wen X
    Physiol Genomics; 2006 Aug; 26(3):163-71. PubMed ID: 16705019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and systems biology: application in drug discovery and development.
    Chakravarti B; Mallik B; Chakravarti DN
    Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in microwave-assisted protein chemistries - can this be integrated into the drug discovery and validation process?
    Sandoval WN; Pham VC; Lill JR
    Drug Discov Today; 2008 Dec; 13(23-24):1075-81. PubMed ID: 18801456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.